Results at 43 months' follow-up of a doubleblind, randomized, prospective clinical trial using intravesical interferon alpha-2b in the prophylaxis of stage pt1 transitional cell carcinoma of the bladder-Reference-Cited by-同舟云学术

Results at 43 months' follow-up of a doubleblind, randomized, prospective clinical trial using intravesical interferon alpha-2b in the prophylaxis of stage pt1 transitional cell carcinoma of the bladder

Published:1997-02 Issue:2 Volume:49 Page:187-190
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Portillo Jose,Martin Bernardo,Hernandez Rafael,Correas Miguel,Gutierrez Jose,Del Valle Jose,Roca Antonio,Vega Antonio,Villanueva Antonio,Gutierrez Ricardo

Publisher

Elsevier BV

Subject

Urology

Reference22 articles.

1. An overview of intravesical therapy for superficial bladder tumors;Herr;J Urol,1987

2. Intravesical mitomycin C installation as a prophylactic treatment of superficial bladder tumor;Kim;J Urol,1988

3. The effect of intravesical thiotepa on the recurrence rate of newly diagnosed superficial bladder cancer. An MRC study;Medical Research Council Working Party on Urological Cancer;Br J Urol,1985

4. Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer;Niijima;Cancer Chemother,1983

5. A longitudinal study of patients with superficial bladder carcinoma successfully treated with intravesical thio-tepa;Nocks;J Urol,1979

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of intravesical therapies on the prevention of recurrence and progression of non‐muscle‐invasive bladder cancer: A systematic review and network meta‐analysis;Cancer Medicine;2020-10-11

2. Emerging therapies in the management of high-risk non-muscle invasive bladder cancer (HRNMIBC);World Journal of Urology;2018-12-04

3. Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis;Journal of Urology;2017-05

4. Tackling non-muscle invasive bladder cancer in the clinic;Expert Review of Anticancer Therapy;2017-04-11

5. Immunotherapy in Bladder Cancer;Current Molecular Pharmacology;2016-09-05